PROVIDER PROFILE · NPI 1659534410

Kathleen VineM.D.

DermatologyNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

7,612

Unique beneficiaries

—

Total services

88,665

Distinct HCPCS

Medicare payment

$1.6M

Peer benchmark

Total Medicare services vs. 960 Dermatology providers in NY — top quintile (cohort median 1,575).

PRESCRIBING · PART D · 2024

Total Rx claims

1,469

Beneficiaries

—

Total drug cost

$306K

Distinct drugs

Brand share

20.6%

Top prescribed drugs

Gentamicin Sulfate221 claims

Triamcinolone Acetonide154 claims

Mupirocin143 claims

Clobetasol Propionate118 claims

Doxycycline Hyclate117 claims

QUALITY · MIPS · 2024

Final MIPS score

0.0

Quality

0.0

Cost

0.0

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

-9.00%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$2K

Payment records

By payment type

Food and Beverage$2K

REFERRAL NETWORK

Where Kathleen Vine's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
David Silvers Pathology · New York, NY	80	157
James Oconnor Internal Medicine · Rockaway Point, NY	30	51
Anne Hardick Dacko Dermatology · Breezy Point, NY	20	49
Jeffrey Zwerling Ophthalmology · Rockaway Park, NY	19	33
MURPHY, ELIZABETH	16	22
HORST, BASIL	13	19
BETH ISRAEL MEDICAL CENTER	11	18

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history